Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5)
•••
QContinuum10
X
View Profile
View Bullboard History
Comment by
QContinuum10
on Jan 10, 2025 12:25pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Evolving business
Indeed, however confusingly, in that approval, there are no similar documents for the approved 100/250 concentrations that make up, at least to these eyes, the actual submission. If Teuto ganged the
...more
(16)
•••
Clongobongo
X
View Profile
View Bullboard History
Comment by
Clongobongo
on Jan 10, 2025 11:49am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Evolving business
It's not that hard, if you look at the Teuto approval, you can see some documents titled with 20 Mg/ml and 50 mg/ml.
(5)
•••
QContinuum10
X
View Profile
View Bullboard History
Comment by
QContinuum10
on Jan 10, 2025 11:41am
RE:RE:RE:RE:RE:RE:RE:RE:RE:Evolving business
A bunch of assumptions in there I think but the general sentiment remains, let's hope Teuto can drive some business. Researching what Teuto has in the review pipeline is a legitimate bear.
(585)
•••
okgonow
X
View Profile
View Bullboard History
Post by
okgonow
on Jan 10, 2025 11:33am
here is one thing i know
i am very happy not to be a shareholder of Tillray the only thing they seem to be able to do is dilute shareholders and loose money thank god we settled with them and we sold our shares ASAP
(16)
•••
Clongobongo
X
View Profile
View Bullboard History
Comment by
Clongobongo
on Jan 10, 2025 11:23am
RE:RE:RE:RE:RE:RE:RE:RE:Evolving business
Here's the thing though, medipharm has 4 of the 36 approvals, and 9 of those approvals are verdemed/ eurofarma. BUT, Verdemed states their products are manufactured in Canada and, it looks like
...more
(5)
•••
QContinuum10
X
View Profile
View Bullboard History
Comment by
QContinuum10
on Jan 10, 2025 11:03am
RE:RE:RE:RE:RE:RE:RE:Evolving business
I take your word for the market composition although even if it is the majority tincture, that still doesn't help Medipharm given, you have to expect, that the other 40-odd other approved products
...more
(16)
•••
Clongobongo
X
View Profile
View Bullboard History
Comment by
Clongobongo
on Jan 10, 2025 10:51am
RE:RE:RE:RE:RE:RE:RE:RE:Evolving business
Low cost in a pharmacy and highly regulated market isn't the same as in cad rec market. Simply check out product prices in reais on pharmacy websites and you'll quickly figure out LABS will
...more
(149)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on Jan 10, 2025 10:42am
RE:RE:RE:RE:RE:RE:RE:Evolving business
Doing my own DD i notice this fact too. Given Teuto is a low cost/ affordable drug provider Not sure that MPL will be able to get high margin profit with Teuto.
(16)
•••
Clongobongo
X
View Profile
View Bullboard History
Comment by
Clongobongo
on Jan 10, 2025 10:28am
RE:RE:RE:RE:RE:RE:Evolving business
The adressable market for medipharm is close or near that 200M as Brazilian pharmacy market is mostly composed of tinctures. There is limited flower from information I gathered. Also, the way
...more
(149)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on Jan 10, 2025 10:27am
RE:RE:RE:RE:RE:RE:Evolving business
Totally agree with you Qcont.
(149)
•••
subaru1
X
View Profile
View Bullboard History
Post by
subaru1
on Jan 10, 2025 10:26am
Come on
Alleyesonme, you know that these numbers aren't good at all, they compare the 3qrt with one of the worst year they had, that is quite easy to do better when you compare with something bad.
...more
(5)
•••
QContinuum10
X
View Profile
View Bullboard History
Comment by
QContinuum10
on Jan 10, 2025 7:02am
RE:RE:RE:RE:RE:Evolving business
Given the total market size is $200M and given, I assume, that addressable market of Medipharm is much less, $2M in one quarter represents far too large of a market share grab. Granted they
...more
(206)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Jan 09, 2025 5:22pm
RE:RE:RE:RE:RE:Evolving business
CANNABIS MediPharm Labs scoops major Brazilian medical cannabis supply deal Laboratrio Teuto is one of Brazil’s top pharma companies, producing more than 700 medications
...more
(53)
•••
CADInvestor12
X
View Profile
View Bullboard History
Comment by
CADInvestor12
on Jan 09, 2025 4:29pm
RE:RE:RE:RE:Evolving business
Fair enough, you're not wrong about how the revenue ramp up will take time. I thought you were referring to initial shipments/ pipeline fill. I have a hunch that Q1 revenue in Brazil will be
...more
(206)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Jan 09, 2025 3:48pm
RE:RE:RE:RE:Evolving business
Initial Shipments are expected to begin in the new year after applicable import and export permits from ANVISA and Health Canada are received.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
LEARN about a Biotech Rising to New Heights and Transforming Regenerative Medicine